These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12022261)

  • 1. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria.
    Poole K
    Curr Pharm Biotechnol; 2002 Jun; 3(2):77-98. PubMed ID: 12022261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance mechanisms: drug efflux across two membranes.
    Zgurskaya HI; Nikaido H
    Mol Microbiol; 2000 Jul; 37(2):219-25. PubMed ID: 10931319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antibiotic efflux in Gram-negative bacteria.
    Zgurskaya HI; Krishnamoorthy G; Tikhonova EB; Lau SY; Stratton KL
    Front Biosci; 2003 Sep; 8():s862-73. PubMed ID: 12957812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are outer-membrane targets the solution for MDR Gram-negative bacteria?
    Walker SS; Black TA
    Drug Discov Today; 2021 Sep; 26(9):2152-2158. PubMed ID: 33798647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.
    Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV
    Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
    Aeschlimann JR
    Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creative targeting of the Gram-negative outer membrane in antibiotic discovery.
    MacNair CR; Tsai CN; Brown ED
    Ann N Y Acad Sci; 2020 Jan; 1459(1):69-85. PubMed ID: 31762048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Agents That Inhibit the Outer Membrane Assembly Machines of Gram-Negative Bacteria.
    Choi U; Lee CR
    J Microbiol Biotechnol; 2019 Jan; 29(1):1-10. PubMed ID: 29996592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and operation of bacterial tripartite multidrug efflux pumps.
    Du D; van Veen HW; Luisi BF
    Trends Microbiol; 2015 May; 23(5):311-9. PubMed ID: 25728476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance in Gram-negative bacteria.
    Poole K
    Curr Opin Microbiol; 2001 Oct; 4(5):500-8. PubMed ID: 11587924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.
    Huwaitat R; McCloskey AP; Gilmore BF; Laverty G
    Future Microbiol; 2016 Jul; 11():955-72. PubMed ID: 27357521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii.
    Vila J; Martí S; Sánchez-Céspedes J
    J Antimicrob Chemother; 2007 Jun; 59(6):1210-5. PubMed ID: 17324960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux-mediated multiresistance in Gram-negative bacteria.
    Poole K
    Clin Microbiol Infect; 2004 Jan; 10(1):12-26. PubMed ID: 14706082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
    Yang X; Goswami S; Gorityala BK; Domalaon R; Lyu Y; Kumar A; Zhanel GG; Schweizer F
    J Med Chem; 2017 May; 60(9):3913-3932. PubMed ID: 28399372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance caused by gram-negative multidrug efflux pumps.
    Nikaido H
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S32-41. PubMed ID: 9710669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.